{"id":"W4230963055","doi":"10.1001/jama.298.9.973-a","title":"Incorrect Data and Wording in: Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial","year":2007,"lang":"en","type":"article","venue":"JAMA","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Procter and Gamble","keywords":"Raloxifene; Medicine; Tamoxifen; Breast cancer; Oncology; Selective estrogen receptor modulator; Antiestrogen; Quality of life (healthcare); Internal medicine; Gynecology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01070408,0.001174499,0.002397138,0.0007375533,0.0007410174,0.002158345,0.0009314416,0.004363929,0.02075505],"category_scores_gemma":[0.05483945,0.0006750276,0.002751729,0.0009179784,0.0008459875,0.001798003,0.0007027368,0.00409319,0.003965563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007350284,"about_ca_system_score_gemma":0.001168523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001613199,"about_ca_topic_score_gemma":0.002284063,"domain_scores_codex":[0.9877346,0.006831085,0.002650467,0.000779619,0.001522786,0.0004813092],"domain_scores_gemma":[0.9743875,0.01845246,0.00406713,0.001096251,0.001443201,0.0005535397],"domain_codex":null,"domain_gemma":"reporting","domain_candidate":"reporting","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.284442,0.001475884,0.02798563,0.008887404,0.009402281,0.001007452,0.0004817495,0.0007414615,0.002155009,0.003313771,0.5952765,0.06483077],"study_design_scores_gemma":[0.5306118,0.007994633,0.1049866,0.003738894,0.02471513,0.0017786,0.0005620313,0.003247842,0.007546333,0.01789269,0.2964189,0.0005066549],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.3138421,0.05786587,0.01048658,0.2016669,0.08782501,0.008012217,0.2432935,0.001197487,0.07581026],"genre_scores_gemma":[0.7399922,0.007741129,0.007371753,0.1487452,0.01025962,0.008206096,0.04634296,0.0007283629,0.03061261],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.995636,"threshold_uncertainty_score":0.06943256,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02800160273142853,"score_gpt":0.3170177616281558,"score_spread":0.2890161588967272,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}